CompletedNot Applicable

Coronary Artery Bypass Grafting With Ascending Aortic Replacement

70 participantsStarted 2013-01-20

Plain-language summary

This retrospective study investigates early outcomes after CABG as well as graft patency rate in patients with concomitant AAR. 35 patients undergoing CABG with concomitant AAR (CABG+AAR group) were case-control matched to 35 patients who received isolated CABG (CABG group) in regard to transit-time flow measurement (TTFM) findings, early and late outcomes.

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Age 18-80 years.
✓. Signed informed consent.
✓. Severe left main stem artery stenosis, or left main equivalent disease (70% or greater stenosis in diameter of the left anterior descending artery, proximal left circumflex artery and right coronary artery).
✓. Ascending aorta greater than 5 cm.

Exclusion criteria

✕. Dissections or urgent/emergent cases.
✕. Redo aortic surgery.
✕. Total aortic arch surgery.

What they're measuring

major adverse cerebral and cardiac events (MACCE).

Timeframe: 12 months

Trial details

NCT IDNCT07071857

SponsorTomsk Cardiology Research Institute

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2021-06-20

View on ClinicalTrials.gov More Coronary Artery Disease trials